ArticleCell proliferation2022

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.

Yiting Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.